Zitran SB 130mg Capsule contains Itraconazole 130mg, a broad-spectrum triazole antifungal agent effective against a variety of fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the treatment of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and other dermatophytic infections. Zitran SB is particularly useful in cases where conventional antifungal therapies have failed or are contraindicated. The capsule formulation ensures optimal bioavailability and patient compliance. It is important to administer Zitran SB with food to enhance absorption. Dosage and duration of therapy should be tailored according to the severity and type of infection, as well as patient response. Caution is advised in patients with hepatic impairment or congestive heart failure, and potential drug interactions must be carefully evaluated due to itraconazole’s effect on cytochrome P450 enzymes. Adverse effects may include gastrointestinal disturbances, headache, and elevated liver enzymes. Regular monitoring of liver function tests is recommended during prolonged therapy. Zitran SB 130mg Capsule should be used under strict medical supervision to ensure safety and efficacy.